Background: Acute post-viral cough (APVC) is a disturbing complaint that may also affect the quality of life. As a result, APVC requires an adequate managing with antitussive medications. In this regard, levodropropizine is an effective and safe peripheral antitussive drug.

Methods: The present retrospective observational study collected data from children with APVC and treated with levodropropizine for up to seven days. Cough intensity and frequency, impact on children's and parents' sleep, school and games, treatment days, satisfaction, and adverse events were considered.

Results: Data from 92 children (mean age 5.5 years) were analyzed globally. Levodropropizine reduced cough intensity and frequency in most children and improved school and game activities and sleep quality in children and their parents. The treatment was safe. Most parents were highly satisfied with the results.

Conclusions: This experience showed that levodropropizine was an effective and safe remedy for children with acute post-viral cough.

Download full-text PDF

Source
http://dx.doi.org/10.23736/S2724-5276.24.07691-2DOI Listing

Publication Analysis

Top Keywords

acute post-viral
12
post-viral cough
12
children acute
8
experience levodropropizine
8
levodropropizine effective
8
effective safe
8
data children
8
cough intensity
8
intensity frequency
8
cough
5

Similar Publications

This review investigates the therapeutic potential of vagal nerve stimulation (VNS) in managing long COVID, a condition marked by persistent symptoms following acute SARS-CoV-2 infection. Long COVID manifests as ongoing fatigue, cognitive impairment, and autonomic dysfunction, hypothesized to arise from sustained inflammatory and neurological dysregulation. The vagus nerve, central to modulating systemic inflammation and autonomic homeostasis, represents a promising therapeutic target for symptom alleviation through VNS.

View Article and Find Full Text PDF

Aim Of Study: This study aimed to compare headache and facial pain prevalence and headache phenotype among people with common upper respiratory tract infections (URTIs).

Clinical Rationale For Study: Headache is a common symptom in viral URTI, but its phenotyping has so far been limited to coronavirus disease 2019 (COVID-19) and influenza. Additionally, the prevalence of facial pain in URTIs has only rarely been discussed in scientific publications.

View Article and Find Full Text PDF

Causal associations between viral infections and acute myocardial injury are not fully understood, with mechanisms potentially involving direct cardiovascular involvement or systemic inflammation. This review explores plausible mechanisms of vascular fibrosis in patients with post-COVID-19 syndrome, focusing on extracellular matrix remodelling. Despite global attention, significant mechanistic or translational breakthroughs in the management of post-viral syndromes remain limited.

View Article and Find Full Text PDF

Epilepsy surgery for postinfectious lesions: A review.

Epilepsy Behav

January 2025

Neuropediatric Clinic and Clinic for Neurorehabilitation, Epilepsy Center for Children and Adolescents, Schoen-Klinik Vogtareuth, Vogtareuth, Germany.

Article Synopsis
  • Cerebral infections lead to structural focal epilepsy, especially in developing countries, where they increase the risk of unprovoked seizures and brain damage during acute phases.
  • Despite many patients suffering from drug-resistant epilepsy post-infection, only a few are referred for surgery, though those with mesial temporal sclerosis (MTS) from early life infections are strong candidates for temporal resections.
  • While surgeries for infections like herpes simplex virus encephalitis are often less successful due to extensive brain damage, removing MTS along with calcified lesions can significantly improve outcomes in selected patients.
View Article and Find Full Text PDF

Viral infections can be acute or chronic, with the immune system pivotal in immunopathogenesis. The potential reversibility of inflammation post-viral elimination is of current interest. This study compares the dynamics of soluble inflammatory mediators (SIM) during and after respiratory infections with SARS-CoV-2 and blood-borne acute and chronic hepatitis C virus (HCV) infections.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!